Luca Faustino Valle

Title(s)HS Assistant Clinical Professor, Radiation Oncology
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer. World J Urol. 2024 Mar 16; 42(1):165. Nikitas J, Kishan A, Chang A, Duriseti S, Nichols NG, Reiter R, Rettig M, Brisbane W, Steinberg ML, Valle L. PMID: 38492111.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Systemic and Tumor-directed Therapy for Oligorecurrent Metastatic Prostate Cancer (SATURN): Primary Endpoint Results from a Phase 2 Clinical Trial. Eur Urol. 2024 Mar 16. Nikitas J, Rettig M, Shen J, Reiter R, Lee A, Steinberg ML, Valle LF, Sachdeva A, Romero T, Calais J, Czernin J, Nickols NG, Kishan AU. PMID: 38494380.
      View in: PubMed   Mentions:    Fields:    
    3. Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. Eur Urol. 2024 Mar 14. Nickols NG, Tsai S, Kane N, Tran S, Ghayouri L, Diaz-Perez S, Thein M, Anderson-Berman N, Eason J, Kishan AU, Steinberg ML, Reiter RE, Lee SP, Gin GE, Kwon R, Chang MG, Chao HH, Solanki AA, Sexton R, Lewis M, Lorentz W, Cheung MK, Gage DL, Duriseti S, Valle L, Berenji G, Aronson WJ, Garraway IP, Rettig MB. PMID: 38490853.
      View in: PubMed   Mentions:    Fields:    
    4. Impact of PSMA PET on Prostate Cancer Management. Curr Treat Options Oncol. 2024 Feb; 25(2):191-205. Weiner AB, Agrawal R, Valle LF, Sonni I, Kishan AU, Rettig MB, Raman SS, Calais J, Boutros PC, Reiter RE. PMID: 38270802.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning. J Magn Reson Imaging. 2024 Jan 24. McGee KP, Cao M, Das IJ, Yu V, Witte RJ, Kishan AU, Valle LF, Wiesinger F, De-Colle C, Cao Y, Breen WG, Traughber BJ. PMID: 38265188.
      View in: PubMed   Mentions:    Fields:    
    6. A systematic review of endometrial cancer clinical research in Africa. Infect Agent Cancer. 2024 Jan 12; 19(1):2. Anakwenze CP, Ewongwo A, Onyewadume L, Oyekan A, Chigbo CO, Valle L, Geng Y, Olapade P, Okwunze K, Lasebikan N, Jhingran A, Balogun OD, Ntekim A. PMID: 38217018; PMCID: PMC10787484.
      View in: PubMed   Mentions:
    7. MRI-Guided Radiation Therapy-An Emerging and Disruptive Process of Care: Healthcare Economic and Policy Considerations. Semin Radiat Oncol. 2024 01; 34(1):4-13. Courtney PT, Valle LF, Raldow AC, Steinberg ML. PMID: 38105092.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. MRI-Guided Radiotherapy for Prostate Cancer: Seeing is Believing. Semin Radiat Oncol. 2024 01; 34(1):45-55. Westley RL, Valle LF, Tree AC, Kishan AU. PMID: 38105093.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials. Int J Radiat Oncol Biol Phys. 2023 Dec 25. Nikitas J, Ong WL, Carrier N, Romero T, Millar J, Steinberg ML, Rettig MB, Boutros PC, Reiter R, Nickols NG, Valle L, McGuire SE, Spratt DE, Souhami L, Roy S, Martin JM, Joseph D, Nabid A, Kishan AU. PMID: 38151191.
      View in: PubMed   Mentions:    Fields:    
    10. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer. JAMA Netw Open. 2023 Dec 01; 6(12):e2345906. Ma TM, Agarwal N, Mahal B, Barragan-Carrillo R, Spratt D, Rettig MB, Valle LF, Steinberg ML, Garraway I, Vapiwala N, Xiang M, Kishan AU. PMID: 38039002; PMCID: PMC10692845.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. In Reply to "Pathogenic/Likely Pathogenic Somatic CDK12 Mutations in Black Men With Prostate Cancer". Oncologist. 2023 Nov 02; 28(11):e1129-e1130. Valle LF, Nickols NG, Yamoah K, Garraway IP, Maxwell KN, Lynch JA. PMID: 37706534; PMCID: PMC10628590.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Impact of Interfractional Bladder and Trigone Displacement and Deformation on Radiation Exposure and Subsequent Acute Genitourinary Toxicity: A Post Hoc Analysis of Patients Treated with Magnetic Resonance Imaging-Guided Prostate Stereotactic Body Radiation Therapy in a Phase 3 Randomized Trial. Int J Radiat Oncol Biol Phys. 2024 Mar 15; 118(4):986-997. Neilsen BK, Ma TM, Akingbemi WO, Neylon J, Casado MC, Sharma S, Sheng K, Ruan D, Low DA, Yang Y, Valle LF, Steinberg ML, Lamb JM, Cao M, Kishan AU. PMID: 37871887.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    13. Bullseye or Tip of the Iceberg: Magnetic Resonance Imaging-visible Disease in Radiorecurrent Prostate Cancer. Eur Urol. 2024 01; 85(1):47-48. Kishan AU, Valle LF, Marks LS. PMID: 37805372.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR. Int J Radiat Oncol Biol Phys. 2023 Oct 04. Ong WL, Nikitas J, Joseph D, Steigler A, Millar J, Valle L, Steinberg ML, Ma TM, Reiter RE, Rettig MB, Nickols NG, Chang A, Zaorsky NG, Spratt DE, Romero T, Kishan AU. PMID: 37802226.
      View in: PubMed   Mentions: 1     Fields:    
    15. MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation. Cancers (Basel). 2023 Sep 21; 15(18). Benitez CM, Steinberg ML, Cao M, Qi XS, Lamb JM, Kishan AU, Valle LF. PMID: 37760626; PMCID: PMC10526919.
      View in: PubMed   Mentions: 1  
    16. Selecting the optimal radiation modality in prostate cancer. Clin Adv Hematol Oncol. 2023 Sep; 21(9):494-501. Valle LF, Kishan AU, Franco A, Ma TM, Nikitas J, Farrell M, Chang AJ, Nickols NG, Steinberg ML. PMID: 37647496.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. J Clin Oncol. 2023 Nov 10; 41(32):5005-5014. Roy S, Romero T, Michalski JM, Feng FY, Efstathiou JA, Lawton CAF, Bolla M, Maingon P, de Reijke T, Joseph D, Ong WL, Sydes MR, Dearnaley DP, Tree AC, Carrier N, Nabid A, Souhami L, Incrocci L, Heemsbergen WD, Pos FJ, Zapatero A, Guerrero A, Alvarez A, San-Segundo CG, Maldonado X, Reiter RE, Rettig MB, Nickols NG, Steinberg ML, Valle LF, Ma TM, Farrell MJ, Neilsen BK, Juarez JE, Deng J, Vangala S, Avril N, Jia AY, Zaorsky NG, Sun Y, Spratt D, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. PMID: 37639648; PMCID: PMC10642893.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans. Oncologist. 2023 06 02; 28(6):e473-e477. Valle LF, Nickols NG, Hausler R, Alba PR, Anglin-Foote T, Perez C, Yamoah K, Rose BS, Kelley MJ, DuVall SL, Garraway IP, Maxwell KN, Lynch JA. PMID: 37084789; PMCID: PMC10243786.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Contemporary Evaluation of Salvage Radiotherapy for Prostate Cancer: Radiotherapy Dose, Field Size, and Use of Hormone Therapy. Eur Urol. 2023 09; 84(3):257-259. Jiang T, Valle LF, Kishan AU. PMID: 37246070.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Transcriptomic Heterogeneity in High-risk Prostate Cancer and Implications for Extraprostatic Disease at Presentation on Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol Oncol. 2023 04; 6(2):224-227. Smith CP, Proudfoot JA, Boutros PC, Reiter RE, Valle L, Rettig MB, Nickols NG, Feng FY, Nguyen PL, Nagar H, Spratt DE, Attard G, Weiner A, Weidhaas JB, Calais J, Ma TM, Davicioni E, Xiang M, Kishan AU. PMID: 36870853.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    21. LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol). BJU Int. 2023 07; 132(1):65-74. Ma TM, Czernin J, Felix C, Alano R, Wilhalme H, Valle L, Steinberg ML, Dahlbom M, Reiter RE, Rettig MB, Cao M, Calais J, Kishan AU. PMID: 36797449.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    22. Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1079-1084. Smith CP, Xiang M, Armstrong WR, Nickols NG, Steinberg ML, Reiter RE, Rettig M, Weiner AB, Shen J, Valle L, Czernin J, Calais J, Kishan AU. PMID: 36863416.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. Multimodality Therapies for Localized Prostate Cancer. Curr Oncol Rep. 2023 03; 25(3):221-229. Valle LF, Jiang T, Weiner AB, Reiter RE, Rettig MB, Shen J, Chang AJ, Nickols NG, Steinberg ML, Kishan AU. PMID: 36723856.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Early Safety and Efficacy Profile of Homogeneously Dosed Salvage Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Recurrences After Low Dose Rate (LDR) Brachytherapy. Clin Genitourin Cancer. 2023 04; 21(2):208-212. Nikitas J, Cao M, Nickols NG, Valle L, Steinberg ML, Kishan AU. PMID: 36739178.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials. J Clin Oncol. 2023 02 01; 41(4):881-892. Ma TM, Sun Y, Malone S, Roach M, Dearnaley D, Pisansky TM, Feng FY, Sandler HM, Efstathiou JA, Syndikus I, Hall EC, Tree AC, Sydes MR, Cruickshank C, Roy S, Bolla M, Maingon P, De Reijke T, Nabid A, Carrier N, Souhami L, Zapatero A, Guerrero A, Alvarez A, Gonzalez San-Segundo C, Maldonado X, Romero T, Steinberg ML, Valle LF, Rettig MB, Nickols NG, Shoag JE, Reiter RE, Zaorsky NG, Jia AY, Garcia JA, Spratt DE, Kishan AU, Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium Investigators. PMID: 36269935; PMCID: PMC9902004.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Pilot trial of topical MTS‑01 application to reduce dermatitis in patients receiving chemoradiotherapy for stage I‑III carcinoma of the anal canal. Int J Oncol. 2022 Jun; 60(6). Citrin D, Valle L, Camphausen K, Cooley-Zgela T, Smart D, Yao M, Mitchell JB, Thompson W, Sereti I, Uldrick T. PMID: 35438186; PMCID: PMC9081975.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    27. Characterizing Twitter Influencers in Radiation Oncology. Adv Radiat Oncol. 2022 Nov-Dec; 7(6):100919. Valle LF, Chu FI, Smith M, Wang C, Lee P, Moghanaki D, Chino FL, Steinberg ML, Raldow AC. PMID: 35694034; PMCID: PMC9184867.
      View in: PubMed   Mentions: 3  
    28. Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome. BJR Case Rep. 2022 Sep; 8(3):20210188. Valle L, Katz J, Duffy A, Hueman M, Wang HW, Hughes M, Sissung T, Figg W, Citrin D. PMID: 36101738; PMCID: PMC9461731.
      View in: PubMed   Mentions:
    29. Evaluating Thresholds to Adopt Hypofractionated Preoperative Radiotherapy as Standard of Care in Sarcoma. Sarcoma. 2021; 2021:3735874. Valle LF, Bernthal N, Eilber FC, Shabason JE, Bedi M, Kalbasi A. PMID: 34720663; PMCID: PMC8556117.
      View in: PubMed   Mentions: 3  
    30. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1). Cancers (Basel). 2021 Sep 12; 13(18). Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Valle L, Ricci S, Cavazza A, Merli F, Pileri SA, Ascani S. PMID: 34572803; PMCID: PMC8465149.
      View in: PubMed   Mentions: 12  
    31. EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 2). Cancers (Basel). 2021 Sep 08; 13(18). Zanelli M, Sanguedolce F, Palicelli A, Zizzo M, Martino G, Caprera C, Fragliasso V, Soriano A, Valle L, Ricci S, Gozzi F, Cimino L, Cavazza A, Merli F, Pileri SA, Ascani S. PMID: 34572754; PMCID: PMC8469260.
      View in: PubMed   Mentions: 12  
    32. Simulated consult and treatment exercise improves radiation oncology trainee confidence and knowledge. J Educ Health Promot. 2021; 10:218. Valle LF, Kundu P, Yoon SM, Pennington JD, Cao M, Lee PP, Kishan AU. PMID: 34395655; PMCID: PMC8318145.
      View in: PubMed   Mentions: 1  
    33. National variation in the delivery of radiation oncology procedures in the non-facility-based setting. Cancer Med. 2021 07; 10(14):4734-4742. Valle LF, Chu FI, Kundu P, Yoon SM, Gilchrist T, Steinberg ML, Raldow AC. PMID: 34076341; PMCID: PMC8290244.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer. Eur Urol. 2021 08; 80(2):142-146. Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, McNutt T, DeWeese TL, Ross AE, Ciezki JP, Tilki D, Karnes RJ, Klein EA, Tosoian JJ, Boutros PC, Nickols NG, Bhat P, Shabsovich D, Juarez JE, Kupelian PA, Rettig MB, Berlin A, Tward JD, Davis BJ, Reiter RE, Steinberg ML, Elashoff D, Horwitz EM, Tendulkar RD, Kishan AU. PMID: 33985797; PMCID: PMC10262978.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Reply to Sungeun Kim, Jae Il Shin, and Jonathan Evan Shoag's Letter to the Editor re: Luca F. Valle, Eric J. Lehrer, Daniela Markovic, et al. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.11.010. Eur Urol. 2021 07; 80(1):e15-e16. Valle LF, Kishan AU. PMID: 33934928.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Use and Impact of Positron Emission Tomography/Computed Tomography Prior to Salvage Radiation Therapy in Men with Biochemical Recurrence After Radical Prostatectomy: A Scoping Review. Eur Urol Oncol. 2021 06; 4(3):339-355. Valle L, Shabsovich D, de Meerleer G, Maurer T, Murphy DG, Nickols NG, Vapiwala N, Calais J, Kishan AU. PMID: 33637464.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    37. Provider-Level Variation in Treatment Planning of Radiation Oncology Procedures in the United States. JCO Oncol Pract. 2021 12; 17(12):e1905-e1912. Valle LF, Chu FI, Yoon SM, Kundu P, Venkat P, Gilchrist T, Steinberg ML, Raldow AC. PMID: 33417480.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER). Eur Urol. 2021 09; 80(3):280-292. Valle LF, Lehrer EJ, Markovic D, Elashoff D, Levin-Epstein R, Karnes RJ, Reiter RE, Rettig M, Calais J, Nickols NG, Dess RT, Spratt DE, Steinberg ML, Nguyen PL, Davis BJ, Zaorsky NG, Kishan AU. PMID: 33309278; PMCID: PMC10262981.
      View in: PubMed   Mentions: 65     Fields:    Translation:Humans
    39. Missing the Near Miss: Recognizing Valuable Learning Opportunities in Radiation Oncology. Pract Radiat Oncol. 2021 May-Jun; 11(3):e256-e262. Kundu P, Jung OS, Valle LF, Edmondson AC, Agazaryan N, Hegde J, Steinberg M, Raldow A. PMID: 32971273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy. Front Oncol. 2020; 10:786. Valle LF, Ruan D, Dang A, Levin-Epstein RG, Patel AP, Weidhaas JB, Nickols NG, Lee PP, Low DA, Qi XS, King CR, Steinberg ML, Kupelian PA, Cao M, Kishan AU. PMID: 32509582; PMCID: PMC7251156.
      View in: PubMed   Mentions: 1  
    41. Clinical Assessment of Prostate Displacement and Planning Target Volume Margins for Stereotactic Body Radiotherapy of Prostate Cancer. Front Oncol. 2020; 10:539. Levin-Epstein R, Qiao-Guan G, Juarez JE, Shen Z, Steinberg ML, Ruan D, Valle L, Nickols NG, Kupelian PA, King CR, Cao M, Kishan AU. PMID: 32373529; PMCID: PMC7177009.
      View in: PubMed   Mentions: 15  
    42. 12-Lipoxygenase is a Critical Mediator of Type II Pneumocyte Senescence, Macrophage Polarization and Pulmonary Fibrosis after Irradiation. Radiat Res. 2019 08; 192(4):367-379. Chung EJ, Reedy JL, Kwon S, Patil S, Valle L, White AO, Citrin DE. PMID: 31373871; PMCID: PMC6816027.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    43. Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists. JAMA Netw Open. 2019 03 01; 2(3):e190932. Valle L, Weng J, Jagsi R, Chu FI, Ahmad S, Steinberg M, Raldow A. PMID: 30901047; PMCID: PMC6583310.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    44. Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists. JAMA Netw Open. 2019 01 04; 2(1):e187377. Weng JK, Valle LF, Nam GE, Chu FI, Steinberg ML, Raldow AC. PMID: 30681710; PMCID: PMC6484553.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. Organ-Specific Toxicities Due to Radiation Therapy in Cancer Patients With or Without HIV Infection: A Systematic Review of the Literature. Front Oncol. 2018; 8:276. Xu MJ, Liewen A, Valle L, Olson AC, Zetola NM, Grover S. PMID: 30105217; PMCID: PMC6077254.
      View in: PubMed   Mentions:
    46. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy. Diagn Interv Radiol. 2018 Jan-Feb; 24(1):46-53. Valle LF, Greer MD, Shih JH, Barrett T, Law YM, Rosenkrantz AB, Shebel H, Muthigi A, Su D, Merino MJ, Wood BJ, Pinto PA, Krauze AV, Kaushal A, Choyke PL, Türkbey B, Citrin DE. PMID: 29317377; PMCID: PMC5765929.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. Patterns of Treatment and Outcomes for Definitive Therapy of Early Stage Non-Small Cell Lung Cancer. Ann Thorac Surg. 2017 Dec; 104(6):1881-1888. Kapadia NS, Valle LF, George JA, Jagsi R, D'Amico TA, Dexter EU, Vigneau FD, Kong FM. PMID: 29106887; PMCID: PMC6889065.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    48. Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA Damage. Int J Radiat Oncol Biol Phys. 2018 02 01; 100(2):344-352. Scroggins BT, Burkeen J, White AO, Chung EJ, Wei D, Chung SI, Valle LF, Patil SS, McKay-Corkum G, Hudak KE, Linehan WM, Citrin DE. PMID: 29157749; PMCID: PMC5777897.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    49. Hepatoid adenocarcinoma of the lung metastasizing to the tonsil. Mol Clin Oncol. 2017 May; 6(5):705-707. Valle L, Thomas J, Kim C, Szabo E, Brown GT, Citrin D, Rajan A. PMID: 28529745; PMCID: PMC5431682.
      View in: PubMed   Mentions: 12  
    50. Hypofractionated whole breast radiotherapy in breast conservation for early-stage breast cancer: a systematic review and meta-analysis of randomized trials. Breast Cancer Res Treat. 2017 04; 162(3):409-417. Valle LF, Agarwal S, Bickel KE, Herchek HA, Nalepinski DC, Kapadia NS. PMID: 28160158.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    51. Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):947-951. Reed A, Valle LF, Shankavaram U, Krauze A, Kaushal A, Schott E, Cooley-Zgela T, Wood B, Pinto P, Choyke P, Turkbey B, Citrin DE. PMID: 28333017; PMCID: PMC5364814.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. In Reply to Moghanaki et al. Int J Radiat Oncol Biol Phys. 2016 10 01; 96(2):483. Valle L, Kapadia N. PMID: 27598816.
      View in: PubMed   Mentions:    Fields:    
    53. Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):360-7. Valle LF, Jagsi R, Bobiak SN, Zornosa C, D'Amico TA, Pisters KM, Dexter EU, Niland JC, Hayman JA, Kapadia NS. PMID: 26853344.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    Luca's Networks
    Concepts (133)
    Derived automatically from this person's publications.
    _
    Co-Authors (41)
    People in Profiles who have published with this person.
    _
    Similar People (59)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _